[How I treat corticosteroid-resistant or relapsed adult patients with primary immune thrombocytopenia].
作者信息
Hou M
机构信息
Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2017 May 14;38(5):375-378. doi: 10.3760/cma.j.issn.0253-2727.2017.05.004.
Abstract
摘要
相似文献
1
[How I treat corticosteroid-resistant or relapsed adult patients with primary immune thrombocytopenia].[我如何治疗原发性免疫性血小板减少症的皮质类固醇抵抗或复发成年患者]
Zhonghua Xue Ye Xue Za Zhi. 2017 May 14;38(5):375-378. doi: 10.3760/cma.j.issn.0253-2727.2017.05.004.
2
Results of treatment in 71 patients with idiopathic thrombocytopenic purpura.71例特发性血小板减少性紫癜患者的治疗结果。
Am J Med Sci. 1961 Sep;242:295-302. doi: 10.1097/00000441-196109000-00004.
3
Treatment of idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜的治疗。
J Am Med Assoc. 1959 Dec 5;171:1911-6. doi: 10.1001/jama.1959.03010320001001.
4
The treatment of idiopathic thrombocytopenic purpura with ACTH and adrenal steroids.促肾上腺皮质激素和肾上腺皮质类固醇治疗特发性血小板减少性紫癜
Ann Paediatr. 1962;198:401-13.
5
Thalidomide induce response in patients with corticosteroid-resistant or relapsed ITP by upregulating Neuropilin-1 expression.沙利度胺通过上调神经纤毛蛋白-1 的表达诱导皮质激素耐药或复发 ITP 患者产生反应。
Int Immunopharmacol. 2019 Jul;72:437-444. doi: 10.1016/j.intimp.2019.04.041.
6
[Observations on corticosteroid treatment of idiopathic thrombocytopenic purpura].[关于皮质类固醇治疗特发性血小板减少性紫癜的观察]
Minerva Med. 1962 Apr 7;53:1047-8.
7
Compounds E and F, and ACTH in the management of idiopathic thrombocytopenic purpura.化合物E和F以及促肾上腺皮质激素在特发性血小板减少性紫癜治疗中的应用
Am J Med Sci. 1954 Jul;228(1):1-15. doi: 10.1097/00000441-195407000-00001.
8
9
[Treatment of idiopathic thrombocytopenic purpura. Effect of ACTH, of corticosteroids and of splenectomy. Analysis of 73 cases].
Rev Hosp Clin Fac Med Sao Paulo. 1962 May-Jun;17:145-61.
10
[Idiopathic thrombocytopenic purpura (ITP) in children].[儿童特发性血小板减少性紫癜（ITP）]
Duodecim. 2011;127(19):2081-6.
本文引用的文献
1
Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia.艾曲泊帕在中国慢性免疫性血小板减少症患者中疗效与安全性的多中心、随机、III期研究
Br J Haematol. 2017 Jan;176(1):101-110. doi: 10.1111/bjh.14380. Epub 2016 Oct 13.
2
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.利妥昔单抗联合重组人血小板生成素对比利妥昔单抗治疗糖皮质激素抵抗或复发的免疫性血小板减少症的多中心随机开放标签研究
Blood. 2015 Mar 5;125(10):1541-7. doi: 10.1182/blood-2014-06-581868. Epub 2015 Jan 9.
3
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.利妥昔单抗治疗成人免疫性血小板减少症的安全性和有效性：一项前瞻性登记研究，纳入 248 例患者。
Blood. 2014 Nov 20;124(22):3228-36. doi: 10.1182/blood-2014-06-582346. Epub 2014 Oct 7.
4
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.利妥昔单抗与三个地塞米松疗程对女性及免疫性血小板减少症病程少于两年者的疗效与脾切除术相似。
Haematologica. 2014 Jul;99(7):1264-71. doi: 10.3324/haematol.2013.103291. Epub 2014 Apr 18.
5
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia.脾切除术与免疫性血小板减少症患者静脉血栓栓塞和脓毒症的发生率。
Blood. 2013 Jun 6;121(23):4782-90. doi: 10.1182/blood-2012-12-467068. Epub 2013 May 1.
6
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.慢性免疫性血小板减少症患者使用罗米司亭的长期治疗：安全性和疗效。
Br J Haematol. 2013 May;161(3):411-23. doi: 10.1111/bjh.12260. Epub 2013 Feb 22.
7
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.依曲泊帕治疗慢性免疫性血小板减少症的安全性和有效性：长期、开放性 EXTEND 研究结果。
Blood. 2013 Jan 17;121(3):537-45. doi: 10.1182/blood-2012-04-425512. Epub 2012 Nov 20.
8
A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.一项重组人血小板生成素治疗原发免疫性血小板减少症患者的多中心随机对照试验。
Int J Hematol. 2012 Aug;96(2):222-8. doi: 10.1007/s12185-012-1124-8. Epub 2012 Jun 30.
9
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.儿童和成人免疫性血小板减少症对利妥昔单抗治疗反应 5 年后的结果。
Blood. 2012 Jun 21;119(25):5989-95. doi: 10.1182/blood-2011-11-393975. Epub 2012 May 7.
10
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.美国血液学会 2011 年免疫性血小板减少症循证实践指南。
Blood. 2011 Apr 21;117(16):4190-207. doi: 10.1182/blood-2010-08-302984. Epub 2011 Feb 16.
Zotero 插件